Clinical and Epidemiological Features of 2009 Pandemic H1N1 Influenza Differ Slightly According to Seroprevalence Status During the Second Wave in the General Population in México
Restricted accessResearch articleFirst published online October, 2012
Clinical and Epidemiological Features of 2009 Pandemic H1N1 Influenza Differ Slightly According to Seroprevalence Status During the Second Wave in the General Population in México
Clinical features of pandemic H1N1 have been derived from lab-confirmed, hospitalized, or critically ill subjects. This report describes the clinical features of H1N1 and their prevalence from non-confirmed subjects according to seroprevalence status in México. The objective was to determine the prevalence of these clinical features from non-confirmed cases of pandemic H1N1 and to compare them according to seroprevalence status in northern Monterrey, México, during 2009, and to identify the predictive signs and symptoms; there have been no prior serologic studies in México.
METHODS:
During November–December 2009, 2,222 volunteers, ages 6–99 years, were categorized into 3 symptomatic groups: influenza-like illness, respiratory illness, and non-respiratory illness. Antibodies against influenza A/H1N1/2009 were determined by a virus-free enzyme-linked immunosorbent assay (ELISA) method. Demographics and clinical presentation were assessed through face-to-face questionnaire, and the association with seroprevalence status was determined and compared.
RESULTS:
Overall seroprevalence was 39%. Of the seropositive subjects, 67% were symptomatic and 33% were asymptomatic. Seventy-one percent of seropositive symptomatic subjects reported respiratory illness, 17% reported non-respiratory symptoms, and 12% reported influenza-like illness. The most common symptoms were rhinorrhea/nasal congestion (93%) and headache (83%). No significant difference was found between the symptom profiles of the seropositive group, compared to the seronegative one, nor of the median duration of symptoms. The seropositive group had a significantly elevated proportion of influenza-like illness (12%), compared to the seronegative group (8%). The proportion of subjects who took days off and who sought medical attention was significantly higher in the seropositive group. No single symptom was associated as a predictor of seropositiveness.
CONCLUSIONS:
One third of the seropositive subjects were asymptomatic, and few had an influenza-like illness. No difference was found in the symptom profiles of the seropositive and seronegative groups. No single symptom predicted seropositiveness. Large scale population studies are needed, especially in México, to characterize clinical syndromes.
Centers for Disease Control and Prevention. Swine influenza A (H1N1) infection in two children: Southern California, March–April 2009. MMWR Morb Mortal Wkly Rep, 2009; 58(15):400–402.
2.
Centers for Disease Control and Prevention. Outbreak of swine-origin influenza A (H1N1) virus infection: Mexico, March–April 2009. MMWR Morb Mortal Wkly Rep, 2009; 58(17):467–470.
3.
Centers for Disease Control and Prevention. Update: infections with a swine-origin influenza A (H1N1) virus: United States and other countries, April 28, 2009. MMWR Morb Mortal Wkly Rep, 2009; 58(16):431–433.
4.
NaffakhN, van der WerfSV. April 2009: an outbreak of swine-origin influenza A(H1N1) virus with evidence for human-to-human transmission. Microbes Infect, 2009; 11(8-9):725–728.
5.
CaoB, LiXW, MaoY, WangJ, LuHZ, ChenYS, et al. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med, 2009; 361(26):2507–2517.
Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 InfluenzaBautistaE, ChotpitayasunondhT, GaoZ, HarperSA, ShawM, UyekiTM, et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med, 2010; 362(18):1708–1719. Erratum in: N Engl J Med 2010;362(21):2039..
8.
Novel Swine-Origin Influenza A (H1N1) Virus Investigation TeamDawoodFS, JainS, FinelliL, ShawMW, LindstromS, GartenRJ, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med, 2009; 360(25):2605–2615. Erratum in: N Engl J Med 2009;361(1):102..
9.
ReedC, AnguloFJ, SwerdlowDL, LipsitchM, MeltzerMI, JerniganD, et al. Estimates of the prevalence of pandemic (H1N1) 2009, United States, April–July 2009. Emerg Infect Dis, 2009; 15(12):2004–2007.
10.
MillerE, HoschlerK, HardelidP, StanfordE, AndrewsN, ZambonM. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet, 2010; 375(9720):1100–1108.
11.
World Health Organization. Human infection with new influenza A (H1N1) virus: clinical observations from Mexico and other affected countries, May 2009. Wkly Epidemiol Rec, 2009; 84(21):185–196. http://www.who.int/wer/2009/wer8421.pdf. Accessed July 17, 2012..
12.
OngAK, ChenMI, LinL, TanAS, NewNW, BarkhamT, et al. Improving the clinical diagnosis of influenza: a comparative analysis of new influenza A (H1N1) cases. PLoS One, 2009; 4(12):e8453..
13.
CallSA, VollenweiderMA, HornungCA, SimelDL, McKinneyWP. Does this patient have influenza?. JAMA, 2005; 293(8):987–997.
14.
Sistema Nacional de Información en Salud. Datos demográficos: población total, hombres y mujeres a mitad de cada año por edad quinquenal según municipio, 2009. http://www.sinais.salud.gob.mx/demograficos/poblacion.html. Web site in Spanish. Accessed July 17, 2012.
15.
CowlingBJ, ChanKH, FangVJ, ChengCK, FungRO, WaiW, et al. Facemasks and hand hygiene to prevent influenza transmission in households: a cluster randomized trial. Ann Intern Med, 2009; 151(7):437–446.
16.
CowlingBJ, FungROP, ChengCKY, FangVJ, ChanKJ,H, SetoWH, et al. Preliminary findings of a randomized trial of non-pharmaceutical interventions to prevent influenza transmission in households. PLoS One, 2008; 3(5):e2101..
17.
BabcockHM, MerzLR, FraserVJ. Is influenza an influenza-like illness? Clinical presentation of influenza in hospitalized patients. Infect Control Hosp Epidemiol, 2006; 27(3):266–270.
18.
AlvarezMM, López-PachecoF, Aguilar-YañezJM, Portillo-LaraR, Mendoza-OchoaGI, García-EchauriS, et al. Specific recognition of influenza A/H1N1/2009 antibodies in human serum: a simple virus-free ELISA method. PLoS One, 2010; 5(4):e10176..
19.
López-PachecoF, Mendoza-OchoaGI, FreidenP, Oropeza-AlmazánY, Chultz-SherryS, Zertuche-GuerraMI, et al. Virus-free ELISA method for the determination of influenza A/H1N1/2009 antibodies in human serum. Influenza Other Respir Viruses, 2011; 5(Suppl 1):135–138.
20.
Aguilar-YáñezJM, Portillo-LaraR, Mendoza-OchoaGI, García-EchauriSA, López-PachecoF, Bulnes-AbundisD, et al. An influenza A/H1N1/2009 hemagglutinin vaccine produced in Escherichia coli. PLoS One, 2010; 5(7):e11694..
21.
DuBoisRM, Aguilar-YañezJM, Mendoza-OchoaGI, Schultz-CherryS, AlvarezMM, WhiteSW, RussellCJ. The receptor binding domain of influenza virus hemagglutinin protein produced in Escherichia coli folds into its native, immunogenic structure. J Virol, 2011; 82(2):865–872.
22.
Elizondo-MontemayorL, AlvarezMM, Hernández-TorreM, Ugalde-CasasPA, Lam-FrancoL, Bustamante-CareagaB, et al. Seroprevalence of antibodies to influenza A/H1N1/2009 among transmission risk groups after the second wave in Mexico, by a virus-free ELISA method. Int J Infect Dis, 2011; 15(11):e781–e786.
ZimmerSM, CrevarCJ, CarterDM, StarkJH, GilesBM, ZimmermanRK, et al. Seroprevalence following the second wave of pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA. PLoS One, 2010; 5(7):e11601..
25.
GilbertGL, CretikosMA, HuestonL, DoukasG, O'TooleB, DwyerDE. Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter. PLoS One, 2010; 5(9):e12562..
26.
Centers for Disease Control and Prevention. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep, 2009; 58(19):521–524.
27.
CauchemezS, DonellyCA, ReedC, GhaniAC, FraserC, KentCK, et al. Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med, 2009; 361(27):2619–2627.
28.
ChenMI, LeeVJ, LimWY, BarrIG, LinRT, KohGC, et al. 2009 influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore. JAMA, 2010; 303(14):1383–1391.
DengY, PangXH, YangP, ShiWX, TianLL, LiuBW, et al. Serological survey of 2009 H1N1 influenza in residents of Beijing, China. Epidemiol Infect, 2011; 139(1):52–58.
31.
ChanYJ, LeeCL, HwangSJ, FungCP, WangFD, YenDH, et al. Seroprevalence of antibodies to pandemic (H1N1) 2009 influenza virus among hospital staff in a medical center in Taiwan. J Chin Med Assoc, 2010; 73(2):62–66.
32.
DowseGK, SmithDW, KellyH, BarrI, LaurieKL, JonesAR, et al. Incidence of pandemic (H1N1) 2009 influenza infection in children and pregnant women during the 2009 influenza season in Western Australia—a seroprevalence study. Med J Aust, 2011; 194(2):68–72.
33.
Centers for Disease Control and Prevention. Swine-origin influenza A (H1N1) virus infections in a school: New York City, April 2009. MMWR Morb Mortal Wkly Rep, 2009; 58(17):470–472.
34.
Perez-PadillaR, de la Rosa-ZamboniD, Ponce de LeonS, HernandezM, Quiñones-FalconiF, BautistaE, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med, 2009; 361(7):680–689.
35.
Domínguez-CheritG, LapinskySE, MaciasAE, PintoR, Espinosa-PerezL, de la TorreA, et al. Critically ill patients with 2009 influenza A (H1N1) in Mexico. J Am Med Assoc, 2009; 302(17):1880–1887.
36.
MunaycoCV, GomezJ, Laguna-TorresVA, ArrascoJ, KochelTJ, FiestasV, et al. Epidemiological and transmissibility analysis of influenza A (H1N1)v in a southern hemisphere setting: Peru. Euro Surveill, 2009; 14(32):19299..
37.
KumarA, ZarychanskiR, PintoR, CookDJ, MarshallJ, LacroixJet al; Canadian Critical Care Trials Group H1N1 Collaborative. Critically ill patients with 2009 influenza A (H1N1) infection in Canada. JAMA, 2009; 302(17):1872–1879.
38.
JainS, KamimotoL, BramleyAM, SchmitzAM, BenoitSR, LouieJ, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April–June 2009. N Engl J Med, 2009; 361(20):1935–1944.
39.
CowlingBJ, ChanKH, FangVJ, LauLL, SoHC, FungRO, et al. Comparative epidemiology of pandemic and seasonal influenza A in households. N Engl J Med, 2010; 362(23):2175–2184.
40.
LibsterR, BugnaJ, CovielloS, HijanoDR, DunaiewskyM, ReynosoN, et al. Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. N Engl J Med, 2010; 362(1):45–55.
41.
HackettS, HillL, PatelJ, RatnarajaN, IfeyinwaA, FaroogiM, et al. Clinical characteristics of paediatric H1N1 admissions in Birmingham, UK. Lancet, 2009; 374(9690):605..
42.
Belgian Working Group on Influenza A(H1N1)v. Influenza A(H1N1)v virus infections in Belgium, May–June 2009. Euro Surveill, 2009; 14(28):19270..
43.
TangJW, TamyahPA, LaiFY, LeeHK, LeeCK, LohTP, et al. Differing symptom patterns in early pandemic vs seasonal influenza infections. Arch Intern Med, 2010; 170(10):861–867.
44.
LouieJK, AcostaM, WinterK, JeanC, GavaliS, SchechterR, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA, 2009; 302(17):1896–1902.
BoivinG, HardyI, TellierG, MaziadeJ. Predicting influenza infections during epidemics with use of a clinical case definition. Clin Infect Dis, 2000; 31(5):1166–1169.
47.
OhmitSE, MontoAS. Symptomatic predictors of influenza virus positivity in children during the influenza season. Clin Infect Dis, 2006; 43(5):564–568.
48.
WilsonN, BakerMG. The emerging influenza pandemic: estimating the case fatality ratio. Euro Surveill, 2009; 14(26):19255..
49.
TuiteAR, GreerAL, WhelanM, WinterAL, LeeB, YanP, et al. Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 influenza. CMAJ, 2010; 182(2):131–136.
50.
HalloranME, FergusonNM, EubankS, LonginiIM, CummingsDA, LewisB, et al. Modeling targeted layered containment of an influenza pandemic in the United States. Proc Natl Acad Sci USA, 2008; 105(12):4639–4644.
51.
YangY, SugimotoJD, HalloranME, BastaNE, ChaoDL, MatrajL, et al. The transmissibility and control of pandemic influenza A (H1N1) virus. Science, 2009; 326(5953):729–733.
